S&P 500 7,387.05 â–ŧ 197.26 (-2.60%) DOW 50,877.30 â–ŧ 684.63 (-1.33%) NASDAQ 25,726.49 â–ŧ 1,104.47 (-4.12%) US Markets Closed â€ĸ 09:12 PM ET

ACOG

Alpha Cognition Inc. Common Stock

Price Chart
Latest Quote

$5.82

-0.09 (-1.52%)
Current Price
Previous Close $5.91
Open $5.90
Day High $6.03
Day Low $5.55
Volume 45,518
Fetched: 2026-06-06T01:12:08
Stock Information
Shares Outstanding 21.77M
Cash Equivalents $54.25M
Revenue $10.83M
Net Income $-25.42M
Sector Healthcare
Industry Biotechnology
Market Cap $126.73M
EPS (TTM) $-1.39
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$72.48M
Sales$10.83M
Income$-25.42M
Book/sh$2.64
Cash/sh$2.49
Employees71
Financial Ratios
Quick Ratio10.66
Current Ratio12.64
Returns & Margins
ROA-29.01%
ROE-51.74%
Gross Margin87.52%
Operating Margin-229.11%
Profit Margin-234.84%
Ownership
Insider Ownership6.55%
Institutional Ownership53.20%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-13.33
P/S11.71
P/B2.21
Analyst Data
Recommendationstrong_buy
Target Price$14.67
Technical Indicators
SMA20$5.92
SMA50$6.13
SMA200$6.39
RSI44.51
ATR0.3161
Shares Float12.12M
Short Float1.09%
Short Ratio4.36
Rel Volume1.26
Performance History
Week-5.98%
Month-8.78%
Quarter+0.52%
6 Months+0.17%
YTD-10.46%
Year-39.22%
10 Years+2.11%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-05 $5.82 45,518
2026-06-04 $5.91 19,100
2026-06-03 $6.08 5,400
2026-06-02 $6.18 15,000
2026-06-01 $6.34 21,300
2026-05-29 $6.19 113,300
2026-05-28 $5.94 19,300
2026-05-27 $5.73 32,200
2026-05-26 $5.88 16,500
2026-05-22 $5.85 29,300
2026-05-21 $5.82 23,700
2026-05-20 $5.89 46,100
2026-05-19 $5.80 15,600
2026-05-18 $5.75 61,400
2026-05-15 $6.02 96,100
2026-05-14 $5.68 37,100
2026-05-13 $5.95 45,900
2026-05-12 $5.49 59,900
2026-05-11 $5.95 8,700
2026-05-08 $6.10 11,700
2026-05-07 $6.09 5,400
2026-05-06 $6.38 32,200
About Alpha Cognition Inc. Common Stock

Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. Alpha Cognition Inc. was founded in 2000 and is headquartered in Grapevine, Texas.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $1,915,323 $0 - -
Cost Of Revenue $1,915,323 $0 - -
Total Revenue $10,220,275 $0 $0 $0
Operating Revenue $10,220,275 $0 $0 $0
Expenses
Total Expenses $32,799,869 $11,548,636 $9,617,813 $13,465,624
Other Income Expense $10,349 $-3,401,755 $-4,075,356 $1,521,881
Other Non Operating Income Expenses $-77,806 $-237,048 - -
Net Non Operating Interest Income Expense $1,899,370 $161,664 $-70,489 $-170,955
Operating Expense $30,884,546 $11,548,636 $9,617,813 $13,465,624
Other Operating Expenses $-81,095 $-463,881 $-260,503 $509,860
Selling And Marketing Expense $1,812,762 $120,973 $19,791 $31,733
General And Administrative Expense $27,226,335 $7,889,912 $4,890,073 $4,016,266
Interest Expense - $185,777 $77,293 $172,880
Total Other Finance Cost - $459,360 - -
Interest Expense Non Operating - $185,777 $77,293 $172,880
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Net Interest Income $1,899,370 $161,664 $-70,489 $-170,955
Interest Income $1,899,370 $161,664 $6,804 $1,925
Normalized Income $-20,758,030 $-11,624,020 $-9,688,302 $-13,636,579
Net Income From Continuing And Discontinued Operation $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Total Operating Income As Reported $-22,660,689 $-12,012,517 $-9,938,093 -
Net Income Common Stockholders $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Net Income $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Net Income Including Noncontrolling Interests $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Net Income Continuous Operations $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Pretax Income $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Interest Income Non Operating $1,899,370 $161,664 $6,804 $1,925
Operating Income $-22,579,594 $-11,548,636 $-9,617,813 $-13,465,624
Depreciation Amortization Depletion Income Statement $58,572 $81,220 $84,479 $90,923
Depreciation And Amortization In Income Statement $58,572 $81,220 $84,479 $90,923
Amortization Of Intangibles Income Statement $21,546 $79,875 $82,376 $82,376
Depreciation Income Statement $37,026 $1,345 $2,103 $8,547
Gross Profit $8,304,952 $0 - -
Special Income Charges - $-39,166 $0 $-5,506
Per Share
Diluted EPS $-1.18 $-2.04 $-3.84 $-4.50
Basic EPS $-1.18 $-2.04 $-3.84 $-4.50
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-22,609,177 $-8,302,709 $-9,526,530 $-13,372,776
Total Unusual Items $88,155 $-3,164,707 $-4,075,356 $1,521,881
Total Unusual Items Excluding Goodwill $88,155 $-3,164,707 $-4,075,356 $1,521,881
Reconciled Depreciation $58,572 $81,220 $84,479 $90,923
EBITDA (Bullshit earnings) $-22,521,022 $-11,467,416 $-13,601,886 $-11,850,895
EBIT $-22,579,594 $-11,548,636 $-13,686,365 $-11,941,818
Diluted Average Shares $17,681,429 $7,247,864 $3,585,440 $2,718,887
Basic Average Shares $17,680,597 $7,247,864 $3,585,440 $2,718,887
Diluted NI Availto Com Stockholders $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Gain On Sale Of Security $88,155 $-3,164,707 $-4,075,356 $1,527,387
Amortization $21,546 $79,875 $82,376 $82,376
Research And Development $1,867,972 $3,920,412 $4,883,973 $8,816,842
Selling General And Administration $29,039,097 $8,010,885 $4,909,864 $4,047,999
Other Gand A $7,142,360 $5,522,832 $1,473,992 $1,386,429
Salaries And Wages $20,083,975 $2,367,080 $3,416,081 $2,629,837
Impairment Of Capital Assets - $39,166 $0 $5,506
Provision For Doubtful Accounts - $55,000 $0 -
Other Special Charges - - $18,489 -
Restructuring And Mergern Acquisition - - - $0
Fetched: 2026-05-30
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $62,138,752 $38,681,858 $-5,235,705 $-1,934,563
Total Assets $79,730,235 $50,736,938 $2,452,170 $2,950,951
Total Non Current Assets $719,963 $485,760 $533,731 $618,210
Goodwill And Other Intangible Assets $391,423 $412,969 $532,010 $614,386
Other Intangible Assets $391,423 $412,969 $532,010 $614,386
Current Assets $79,010,272 $50,251,178 $1,918,439 $2,332,741
Current Deferred Assets $223,096 $0 - -
Restricted Cash $58,400 $17,872 $90,413 $0
Prepaid Assets $3,119,823 $818,537 $266,280 $249,045
Inventory $5,123,496 $615,133 $0 -
Receivables $4,438,668 $253,426 $157,586 $0
Other Receivables $202,532 $253,426 $100,036 -
Accounts Receivable $4,236,136 $0 - -
Cash Cash Equivalents And Short Term Investments $66,046,789 $48,546,210 $1,404,160 $2,083,696
Cash And Cash Equivalents $66,046,789 $48,546,210 $1,404,160 $2,083,696
Other Non Current Assets - $45,714 - -
Loans Receivable - $0 $57,550 $0
Other Current Assets - - $366,316 $249,045
Cash Financial - - $1,404,160 $2,083,696
Debt
Total Debt - $911,463 $1,211,463 $1,211,463
Current Debt And Capital Lease Obligation - $911,463 $1,211,463 $1,211,463
Current Debt - $911,463 $1,211,463 $1,211,463
Other Current Borrowings - $911,463 $1,211,463 $1,211,463
Liabilities
Total Liabilities Net Minority Interest $17,200,060 $11,642,111 $7,155,865 $4,271,128
Total Non Current Liabilities Net Minority Interest $8,069,985 $8,291,359 $4,539,872 $214,284
Other Non Current Liabilities $47,181 $102,783 $84,125 $8,295
Derivative Product Liabilities $7,986,860 $8,188,576 $4,455,747 $205,989
Non Current Deferred Liabilities $35,944 $0 - -
Current Liabilities $9,130,075 $3,350,752 $2,615,993 $4,056,844
Current Deferred Liabilities $153,171 $0 $10,413 $0
Payables And Accrued Expenses $8,976,904 $2,439,289 $1,394,117 $2,294,721
Payables $3,067,616 $872,676 $475,553 $2,016,057
Accounts Payable $3,067,616 $872,676 $475,553 $2,016,057
Current Notes Payable - - $1,220,372 $1,211,463
Equity
Common Stock Equity $62,530,113 $39,094,765 $-4,703,757 $-1,320,177
Preferred Stock Equity $62 $62 $62 $62
Total Equity Gross Minority Interest $62,530,175 $39,094,827 $-4,703,695 $-1,320,177
Stockholders Equity $62,530,175 $39,094,827 $-4,703,695 $-1,320,177
Gains Losses Not Affecting Retained Earnings $-104,301 $-104,301 $-104,301 $8,407,731
Other Equity Adjustments $-104,301 $-104,301 $-104,301 $8,407,731
Retained Earnings $-97,106,775 $-76,436,900 $-61,648,173 $-49,986,851
Other
Ordinary Shares Number $21,742,104 $16,019,787 $4,728,359 $2,720,938
Share Issued $21,742,104 $16,019,787 $4,728,359 $2,720,938
Tangible Book Value $62,138,690 $38,681,796 $-5,235,767 $-1,934,563
Invested Capital $62,530,113 $40,006,228 $-3,492,294 $-108,714
Working Capital $69,880,197 $46,900,426 $-697,554 $-1,724,103
Total Capitalization $62,530,175 $39,094,827 $-4,703,695 $-1,320,177
Additional Paid In Capital $25,849,516 $16,507,736 $17,288,430 -
Capital Stock $133,891,735 $99,128,292 $39,760,349 $40,258,943
Common Stock $133,891,673 $99,128,230 $39,760,287 $40,258,943
Preferred Stock $62 $62 $62 $62
Non Current Deferred Revenue $35,944 $0 - -
Current Deferred Revenue $153,171 $0 $10,413 $0
Current Accrued Expenses $5,909,288 $1,566,613 $918,564 $278,664
Net PPE $328,540 $27,077 $1,721 $3,824
Gross PPE $328,540 $27,077 $12,370 $3,824
Other Properties $328,540 $27,077 $12,370 $3,824
Finished Goods $672,700 $0 - -
Work In Process $725,460 $615,133 $0 -
Raw Materials $3,725,336 $0 $0 -
Accumulated Depreciation - $-11,994 $-10,649 -
Construction In Progress - $18,000 $0 -
Pensionand Other Post Retirement Benefit Plans Current - - $791,280 $550,660
Dueto Related Parties Current - - - -
Fetched: 2026-05-30
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $-20,673,856 $-7,782,355 $-8,799,565 $-9,246,526
Operating Activities
Operating Cash Flow $-20,380,367 $-7,755,654 $-8,799,565 $-9,241,650
Cash Flow From Continuing Operating Activities $-20,380,367 $-7,755,654 $-8,799,565 $-9,241,650
Operating Gains Losses $-70,155 $3,164,707 $4,085,284 $-1,823,444
Investing Activities
Capital Expenditure $-293,489 $-26,701 - $-4,876
Investing Cash Flow $-293,489 $-26,701 $0 $-4,876
Cash Flow From Continuing Investing Activities $-293,489 $-26,701 $0 $-4,876
Financing Activities
Issuance Of Capital Stock $34,321,975 $56,541,384 $9,223,587 $0
Financing Cash Flow $38,214,963 $54,851,864 $8,230,015 $24,785
Cash Flow From Continuing Financing Activities $38,214,963 $54,851,864 $8,230,015 $24,785
Net Other Financing Charges $-2,506,693 $-6,236,320 $-965,572 -
Net Common Stock Issuance $34,321,975 $56,541,384 $9,223,587 $0
Common Stock Issuance $34,321,975 $56,541,384 $9,223,587 $0
Cash Dividends Paid - - $0 $0
Other
Repayment Of Debt $-911,463 $-300,000 $-55,000 $0
Issuance Of Debt $0 $4,545,000 $0 -
Interest Paid Supplemental Data $4,894 $37,754 $59,777 $16,000
End Cash Position $66,105,189 $48,564,082 $1,494,573 $2,083,696
Beginning Cash Position $48,564,082 $1,494,573 $2,083,696 $11,301,793
Changes In Cash $17,541,107 $47,069,509 $-569,550 $-9,221,741
Proceeds From Stock Option Exercised $7,311,144 $301,800 $27,000 $40,785
Net Issuance Payments Of Debt $-911,463 $4,245,000 $-55,000 $0
Net Long Term Debt Issuance $-911,463 $4,245,000 $-55,000 $0
Long Term Debt Payments $-911,463 $-300,000 $-55,000 $0
Long Term Debt Issuance $0 $4,545,000 $0 -
Net PPE Purchase And Sale $-293,489 $-26,701 $0 $-4,876
Purchase Of PPE $-293,489 $-26,701 $0 $-4,876
Change In Working Capital $-4,618,883 $-241,679 $-1,568,535 $2,730,088
Change In Other Working Capital $95,535 - - -
Change In Payables And Accrued Expense $6,520,855 $1,045,172 $-1,451,264 $2,110,301
Change In Payable $6,520,855 $1,045,172 $-1,451,264 $2,110,301
Change In Account Payable $6,520,855 $1,045,172 $-1,451,264 $2,110,301
Change In Prepaid Assets $-2,490,774 $-671,718 $-117,271 $619,787
Change In Inventory $-4,508,363 $-615,133 $0 -
Change In Receivables $-4,236,136 $0 - -
Changes In Account Receivables $-4,236,136 $0 - -
Other Non Cash Items $-2,551 $2,802,998 $-6,720 $168,168
Stock Based Compensation $4,922,525 $1,131,661 $2,369,585 $1,701,807
Provisionand Write Offof Assets $0 $55,000 $0 -
Asset Impairment Charge $0 $39,166 $0 $5,506
Depreciation Amortization Depletion $58,572 $81,220 $84,479 $90,923
Depreciation And Amortization $58,572 $81,220 $84,479 $90,923
Gain Loss On Investment Securities $-88,155 $3,164,707 $4,085,284 $-1,823,444
Gain Loss On Sale Of PPE $18,000 $0 - -
Net Income From Continuing Operations $-20,669,875 $-14,788,727 $-13,763,658 $-12,114,698
Effect Of Exchange Rate Changes - $0 $-19,573 $3,644
Income Tax Paid Supplemental Data - - $0 $0
Interest Paid Cff - - $-70,777 $-16,000
Amortization Cash Flow - - $82,376 $82,376
Amortization Of Intangibles - - $82,376 $82,376
Depreciation - - $2,103 $8,547
Net Business Purchase And Sale - - - $0
Sale Of Business - - - $0
Net Intangibles Purchase And Sale - - - $0
Purchase Of Intangibles - - - $0
Change In Tax Payable - - - -
Change In Income Tax Payable - - - -
Fetched: 2026-05-30